Tag: national coverage determination

WASHINGTON – The Council for Quality Respiratory Care in a statement today encouraged CMS to reconsider eliminating the CMN for home oxygen therapy. The CQRC, a coalition of the nation’s largest respiratory providers and manufacturers, says doing that would replace “objective testing ordered by a patient’s physician for the subjective decision-making of Medicare contractors.” “We are highly supportive of allowing acute patients to receive oxygen therapy outside...

These were some of the reactions of industry stakeholders to the news of CMS’s proposed national coverage determination for home oxygen therapy: “Groundbreaking.” “We haven’t seen something this major happen in a long time.” “This obliterates everything that we’ve held to be immovable ground for oxygen coverage.”  If you’re like me, when you first saw the news on that Friday before a long holiday weekend (classic CMS move,...

WASHINGTON – CMS’s proposed national coverage determination for home oxygen therapy – its first revision since 1993 – makes “groundbreaking” changes, including expanding access for acute conditions and removing the CMN requirement.  Industry stakeholders say the agency is proposing the changes largely as a result of the COVID-19 pandemic, which significantly increased the number of people needing oxygen and exposed issues with the current NCD.  “We...

WASHINGTON – CMS wants to modify the national coverage determination (NCD) for home use of oxygen to expand patient access to oxygen and oxygen equipment and permit the Medicare Administrative Contractors (MACs) to cover their use to treat cluster headaches and other acute conditions, according to a proposed decision memo.  The agency also wants to remove the NCD for home oxygen use to treat cluster headache, ending coverage with evidence development.  The scope of the decision...